Diagnovus Launches Real-Time PCR Assay to Gauge Barrett's Esophagus Cancer Risk

Oct 10, 2013

|

Premium

Molecular diagnostics company Diagnovus this week launched a real-time PCR-based assay to measure a patient's risk of developing a specific type of esophageal cancer from the condition Barrett's esophagus.

The test, called Engauge GI-Barrett's Esophagus, uses real-time PCR performed on Life Technologies' ViiA 7 system to measure methylation of eight biomarkers in biopsied tissue from Barrett's esophagus patients to determine their risk of progression to high-grade dysplasia or esophageal adenocarcinoma.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

Recent Headlines from
Precision Oncology News

The Scan

Little More Regulation Wanted

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Medical Test for Tax Reasons

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Act Proposed to Combat Interference

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

PLOS Studies Examine Genes Co-Expressed in Depression, More

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

Featured White Papers

Cell-Based Therapies – Be on the Safe Side

Poster: Next Generation Cellular Therapeutic Technologies — Rapid Detection of Bacterial Contamination

Application Note: How to Pipette PCR Master Mix for Increased Accuracy in qPCR Results

Application Note: Benchmarking of the Microsart® AMP Mycoplasma kit with Products of Two Other Suppliers

Jul

24

Featured Webinar

Comparison of Group B Streptococcus Molecular Assays for Routine Screening in Pregnant Women

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul

31

Featured Webinar

Considerations and Impact of Implementing Targeted NGS in Myeloid Malignancies

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

Menu